Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

Completed · Phase 2

Conditions studied: Glucosephosphate Dehydrogenase Deficiency, Hyperbilirubinemia, Hemolytic Disease of Newborn

In brief

OBJECTIVES: I. Compare the efficacy of preventive vs. therapeutic tin mesoporphyrin in direct Coombs' test-positive ABO hemolytic disease of the newborn and glucose-6-phosphate dehydrogenase deficiency in infants living in Greece. II. Assess the safety of tin mesoporphyrin in high-risk newborns.

Key facts

Study ID

NCT00004381

Run by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Starts

1999-12-01

Last updated by the study team

2005-06-24

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

Where it is running

• New England Medical Center Hospital — Boston, Massachusetts, United States
• Rockefeller University Hospital — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.